10x Genomics (MEX:TXG) Long-Term Debt: MXN0 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:TXG 10x Genomics Inc MEX:TXG
60 GF Score
Price MXN335.54
GF Value MXN145.06
! 8 Warning Signs
View Full Analysis

What is 10x Genomics Long-Term Debt?

10x Genomics MEX:TXG 60 Long-Term Debt is MXN0 Mil as of Mar. 2026. GuruFocus rates MEX:TXG with a GF Score™ of 60/100 and a GF Value™ of MXN145.06. The stock has 8 warning signs investors should review.

10x Genomics's Long-Term Debt for the quarter that ended in Mar. 2026 was MXN0 Mil.

10x Genomics  (MEX:TXG) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

10x Genomics Long-Term Debt Related Terms

10x Genomics Long-Term Debt Historical Data

* Premium members only.

The historical data trend for 10x Genomics's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

10x Genomics Long-Term Debt Chart

10x Genomics Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 0.00

10x Genomics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
MEX:TXG
60GF Score
10x Genomics Inc MEX:TXG
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of MXN0 Mil mean?
10x Genomics (MEX:TXG) has a Long-Term Debt of MXN0 Mil as of Mar. 2026.
Is 10x Genomics' Long-Term Debt too high?
10x Genomics' current Long-Term Debt is MXN0 Mil. Overall, 10x Genomics has a GF Score™ of 60/100, reflecting its overall financial health beyond just this single metric.
How does 10x Genomics' Long-Term Debt compare to DOCS and WAY?
10x Genomics' Long-Term Debt of MXN0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Healthcare Providers & Services company?
A good Long-Term Debt depends on the Healthcare Providers & Services industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. 10x Genomics's current Long-Term Debt is MXN0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 10x Genomics stock overvalued right now?
10x Genomics (MEX:TXG) has a current Long-Term Debt of MXN0 Mil. The stock's GF Value™ is MXN145.06, compared to a current price of MXN335.54 — trading 131.3% above its estimated fair value. The current Long-Term Debt is MXN0 Mil. 10x Genomics' overall GF Score™ is 60/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For 10x Genomics (MEX:TXG), the current Long-Term Debt is MXN0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is 10x Genomics (MEX:TXG) Overvalued in 2026?

Based on GuruFocus' analysis, 10x Genomics stock appears to be overvalued. The current stock price of MXN335.54 is trading 131.3% above its estimated GF Value™ of MXN145.06.

Key valuation signals for MEX:TXG:

  • Long-Term Debt: MXN0 Mil
  • GF Value™: MXN145.06 vs. price of MXN335.54 (131.3% above fair value)
  • GF Score™: 60/100 with 8 warning signs

No single metric tells the full story. See the MEX:TXG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

10x Genomics Business Description

Other Exchanges TXG:USA0A88:UK1KJ:Germany
Address 6230 Stoneridge Mall Road, Pleasanton, CA, USA, 94588
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).
60GF Score

Get the complete analysis for MEX:TXG

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN335.54
Price
MXN145.06
GF Value